ID27757A - Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat - Google Patents

Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat

Info

Publication number
ID27757A
ID27757A IDW20010688A ID20010688A ID27757A ID 27757 A ID27757 A ID 27757A ID W20010688 A IDW20010688 A ID W20010688A ID 20010688 A ID20010688 A ID 20010688A ID 27757 A ID27757 A ID 27757A
Authority
ID
Indonesia
Prior art keywords
preparation
new substituted
compounds
indolinona
medicines
Prior art date
Application number
IDW20010688A
Other languages
English (en)
Indonesian (id)
Inventor
Rainer Dr Walter
Armin Dr Heckel
Gerald Dr Roth
Wolfgang Dr Crell
Frank Dr Himmelsbach
Wolfgang Dr Eberlein
Jacobus C A Van Dr Meel
Norbert Dr Redemann
Wolter Dr Spevak
Ulrike Tonisch Dr Grunt
Thomas Von Dr Ruden
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19844003A external-priority patent/DE19844003A1/de
Priority claimed from DE19937496A external-priority patent/DE19937496A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID27757A publication Critical patent/ID27757A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20010688A 1998-09-25 1999-09-22 Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat ID27757A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19844003A DE19844003A1 (de) 1998-09-25 1998-09-25 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19937496A DE19937496A1 (de) 1999-08-07 1999-08-07 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ID27757A true ID27757A (id) 2001-04-26

Family

ID=26049076

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010688A ID27757A (id) 1998-09-25 1999-09-22 Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat

Country Status (28)

Country Link
US (1) US6855710B2 (xx)
EP (1) EP1115704B1 (xx)
JP (1) JP2002525356A (xx)
KR (1) KR20010085841A (xx)
CN (1) CN1319090A (xx)
AT (1) ATE243195T1 (xx)
AU (1) AU763361B2 (xx)
BG (1) BG105327A (xx)
BR (1) BR9914065A (xx)
CA (1) CA2342622A1 (xx)
DE (1) DE59906030D1 (xx)
DK (1) DK1115704T3 (xx)
EA (1) EA200100320A1 (xx)
EE (1) EE200100184A (xx)
ES (1) ES2196860T3 (xx)
HR (1) HRP20010216A2 (xx)
HU (1) HUP0104973A3 (xx)
ID (1) ID27757A (xx)
IL (1) IL141622A0 (xx)
NO (1) NO20011477D0 (xx)
NZ (1) NZ510845A (xx)
PL (1) PL346898A1 (xx)
PT (1) PT1115704E (xx)
SI (1) SI1115704T1 (xx)
SK (1) SK4032001A3 (xx)
TR (1) TR200100854T2 (xx)
WO (1) WO2000018734A1 (xx)
YU (1) YU21301A (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
CA2461812C (en) * 2001-09-27 2011-09-20 Allergan, Inc. 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
MXPA04009329A (es) 2002-03-26 2005-01-25 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y usos de los mismos.
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
US7514468B2 (en) 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
DE10233366A1 (de) * 2002-07-23 2004-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
PE20040701A1 (es) * 2002-07-23 2004-11-30 Boehringer Ingelheim Pharma Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos
DE10237423A1 (de) * 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen
US20040204458A1 (en) 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
RS20050174A (xx) * 2002-08-29 2007-06-04 Boehringer Ingelheim Pharmaceuticals Inc., Derivati 3-(sulfonamidoetil)-indola za primenu kao mimetici glukokortikoida u lečenju zapaljenskih,alergijskih i proliferativnih oboljenja
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
US20050043233A1 (en) 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
DE602004017884D1 (de) 2003-10-03 2009-01-02 Boehringer Ingelheim Pharma Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
KR101165863B1 (ko) 2004-03-11 2012-07-13 액테리온 파마슈티칼 리미티드 인돌-1-일-아세트산 유도체
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
US7741361B2 (en) 2004-12-27 2010-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CA2605688A1 (en) 2005-04-28 2006-11-02 Boehringer Ingelheim International Gmbh Compounds for treating inflammatory diseases
WO2008070507A2 (en) 2006-12-06 2008-06-12 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
RU2482877C2 (ru) * 2006-12-11 2013-05-27 Дженентек, Инк. Композиции и способы для лечения опухоли
CN101273991B (zh) * 2007-03-28 2010-05-26 广东同德药业有限公司 四氢吲哚酮/四氢吲唑酮/四氢咔唑衍生物及其盐在制备抗病毒药物中的应用
NZ585799A (en) * 2007-12-03 2012-04-27 Boehringer Ingelheim Int Process for the manufacture of an indolinone derivative in particular 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone
UY31506A1 (es) 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
DK2238108T3 (da) * 2008-01-25 2012-10-15 Boehringer Ingelheim Int Saltformer af et 6-fluor-1,2-dihydro-2-oxo-3h-indol-3-yliden-derivat, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende de samme
AU2009256289A1 (en) 2008-06-06 2009-12-10 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
TW201011002A (en) 2008-07-29 2010-03-16 Boehringer Ingelheim Int New compounds
JPWO2013137371A1 (ja) * 2012-03-15 2015-08-03 興和株式会社 新規ピリミジン化合物及びそれらを含有する医薬
CN103664737A (zh) * 2012-09-25 2014-03-26 杨子娇 一类治疗房角狭窄的化合物及其用途
WO2019152977A2 (en) 2018-02-05 2019-08-08 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
CN114957084B (zh) * 2022-01-21 2023-05-09 九江学院 一种吲哚酮类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease

Also Published As

Publication number Publication date
US6855710B2 (en) 2005-02-15
CN1319090A (zh) 2001-10-24
DE59906030D1 (de) 2003-07-24
BR9914065A (pt) 2001-06-19
AU6086399A (en) 2000-04-17
SK4032001A3 (en) 2001-11-06
HRP20010216A2 (en) 2002-04-30
JP2002525356A (ja) 2002-08-13
EP1115704A1 (de) 2001-07-18
ES2196860T3 (es) 2003-12-16
IL141622A0 (en) 2002-03-10
SI1115704T1 (en) 2003-12-31
YU21301A (sh) 2003-04-30
EE200100184A (et) 2002-08-15
TR200100854T2 (tr) 2001-12-21
PL346898A1 (en) 2002-03-11
EP1115704B1 (de) 2003-06-18
PT1115704E (pt) 2003-11-28
HUP0104973A3 (en) 2002-06-28
BG105327A (en) 2001-12-29
WO2000018734A1 (de) 2000-04-06
NO20011477L (no) 2001-03-22
CA2342622A1 (en) 2000-04-06
KR20010085841A (ko) 2001-09-07
US20040058978A1 (en) 2004-03-25
HUP0104973A2 (hu) 2002-04-29
AU763361B2 (en) 2003-07-17
NZ510845A (en) 2003-10-31
NO20011477D0 (no) 2001-03-22
EA200100320A1 (ru) 2001-10-22
ATE243195T1 (de) 2003-07-15
DK1115704T3 (da) 2003-09-29

Similar Documents

Publication Publication Date Title
ID27757A (id) Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat
MY127956A (en) Substituted indolines which inhibit receptor tyrosine kinases
WO2002024700A3 (en) SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES
YU59800A (sh) Supstituisani indolinoni sa inhibitorskim dejstom na kinaze i ciklin /cdk komplekse
HK1047098A1 (en) Tri-aryl acid derivatives as ppar receptor ligands.
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
DK0665844T3 (da) Substituerede benzylaminoquinuclidinforbindelser som antagonister af substans P
FI970150A0 (fi) Substituoituja pyrimidiiniyhdisteitä ja niiden käyttö
MXPA02010627A (es) Derivados de 2-acil-indol y su uso como farmaco antitumoral.
DE69207301T2 (de) Substituierte 3-Piperazinylalkyl 2,3-Dihydro-4H-1,3-Benzoxazin-4-One, deren Herstellung und Verwendung in Heilkunde
ECSP034776A (es) Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos
BR0309744A (pt) Ligandos receptores de melanocortina e composição compreendendo os mesmos
AU1027992A (en) Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles, 1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
MY122095A (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
BR0214488A (pt) Derivados de benzotiazol
ATE325116T1 (de) Farnesyltransferasehemmende 4- heterocyclylchinolin- und chinazolinderivate
UY26308A1 (es) Nuevas indolinonas sustituidas, su preparación y su empleo como medicamentos
HUP0000854A2 (hu) 4-[6-Fluor-(1H)-indol-3-il]-1,2,3,6-tetrahidropiridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás mindezek előállítására
YU3701A (sh) Supstituisani fenilamidini sa antitrombskim dejstvom
ID28292A (id) Senyawa 2,3,3a,4,9,9a-heksahidro-8-hidroksi-1h-benz (f) indol baru metoda untuk memproduksinya dan penggunaannya sebagai obat-obatan
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler
TH57154B (th) ซับสทิทิวเทด อินโดลิโนน ชนิดใหม่, การเตรียมสารเหล่านี้และการใช้สารเหล่านี้เป็นสารผสมทางเภสัช
TH59387B (th) อนุพันธ์ n-ไตรอะโซลอิลเมทธิล-พิเพอราซิน เป็น นิวโรไคนิน-รีเซปเตอร์แอนทาโกนิสท์
TH23743A (th) สารประกอบเคมี
MX9708021A (es) Fenilamidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparacion.